Acasti Pharma | ACST - Equity Capital And Reserves


Acasti Pharma reported $62.82M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Acasti Pharma USD 62.82M 732K Sep/2025
Addus HomeCare USD 1.05B 28.12M Sep/2025
Amarin USD 458.89M 6.03M Sep/2025
Cassava Sciences USD 81.57M 6.4M Sep/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Option Care Health USD 1.36B 1.29M Sep/2025
Organigram Holdings CAD 349.13M 36.37M Sep/2025
Tilray USD 1.51B 1.22B Mar/2025